Straits Times Index
3,426.47 -3.98 (-0.12%) Nikkei
37,667.41 -202.10 (-0.53%) Hang Seng
17,021.31 +16.34 (+0.10%) FTSE 100
8,285.71 +99.36 (+1.21%) Bitcoin USD
68,060.91 +991.10 (+1.48%) CMC Crypto 200
1,378.93 +48.32 (+3.63%)
Dassault Systèmes SE (DASTF)
- Business Wire
Eisai Selects Medidata’s Clinical Data Studio to Enhance and Modernize Clinical Trial Efficiency and Patient Experience
NEW YORK, July 26, 2024--Medidata, a Dassault Systèmes brand and leading provider of clinical trial solutions to the life sciences industry, today announced Eisai Inc. ("Eisai"), the U.S. pharmaceutical subsidiary of Tokyo-based Eisai Co., Ltd., as one of the first customers to harness its recently announced AI-driven Medidata Clinical Data Studio. Eisai Inc., will leverage this innovative data experience to gain unprecedented control over its clinical data, enable the execution of scalable and
- GlobeNewswire
Dassault Systèmes: Availability of the 2024 Half-year Financial Report
Press ReleaseVELIZY-VILLACOUBLAY, France — July 25, 2024 Availability of Dassault Systèmes’ 2024 Half-Year Financial Report (IFRS Half-Year Consolidated Condensed Financial Statements) Dassault Systèmes (Euronext Paris: FR0014003TT8, DSY.PA) today announced the availability to the public and the filing of its Half-Year Financial Report as of June 30, 2024 with the French Autorité des marchés financiers. The half-year condensed consolidated financial statements included in this report are establi
- Business Wire
ASICS and Dassault Systèmes Demonstrate On-Demand, Personalized Footwear
VELIZY-VILLACOUBLAY, France, July 25, 2024--Dassault Systèmes (Euronext Paris: FR0014003TT8, DSY.PA) and ASICS have jointly opened a studio in Paris to test a new service providing on-demand sockliners personalized for individual foot shape.
